Intracranial and Extracranial Atherosclerosis: More Similar Than Different? =========================================================================== * L.L. Chan Atherosclerosis involves gradual arterial hardening secondary to the building up of lipid-laden plaques in the vessel wall, which may cause vascular stenosis, thromboembolism, or overgrowth across perforator arterial ostia.1,2 Despite common vascular risk factors and overlapping atherogenic molecular pathways, differential prevalence, onset, and progression of atherosclerosis exist across arterial beds and ethnic groups (eg, inordinate prevalence of intracranial atherosclerosis in Asians and Africans in epidemiologic data), suggesting multifactorial variation underlying the expression of this systemic disease.2⇓⇓⇓⇓⇓–8 Intracranial large-artery atherosclerosis is a known strong risk factor for ischemic stroke, associated with a high risk of recurrent ischemic stroke.1 However, it is generally perceived to be etiologically different from extracranial disease.3⇓–5,8 Recent technologic advances improving the clinical applicability of 3D high-resolution intracranial vessel wall imaging challenge these traditional assumptions.5⇓–7,9 Because vascular remodeling in the form of compensatory dilation may occur secondary to plaque formation, traditional lumen-based approaches such as CT or MR angiography on which some historical epidemiologic or symptomatic stroke studies were based could underestimate the true prevalence of underlying intracranial atherosclerosis.4,6⇓⇓⇓–10 In contrast, vessel wall imaging allows simultaneous study of both stenotic and nonstenotic atherosclerotic vessel wall lesions, better reflecting the true prevalence of intracranial atherosclerotic burden.7,9 Hence, vessel wall imaging offers the opportunity to elucidate the pathophysiologic underpinnings of intracranial large-artery atherosclerosis, which may serve as potential targets for stroke prevention and treatment.5,7 Recent interest has been directed to the reliability of vessel wall imaging in epidemiologic characterization of intracranial atherosclerotic burden in population-based studies.7,9 The article by Zwartbol et al11 in this issue of the *American Journal of Neuroradiology* offers incipient evidence of an association of extracranial atherosclerosis and intracranial atherosclerotic burden based on a simple uniparametric score of vessel wall lesion count. Using 7T vessel wall MR imaging, the authors reported on the intracranial atherosclerotic burden on a cross-sectional analysis of 130 patients with second manifestations of arterial disease in various vessel beds, recruited under the SMART-MR study. Besides a clear majority (96%) of patients having at least 1 intracranial arterial vessel wall lesion, there is a significant association of intracranial atherosclerotic burden with atherosclerotic disease in all examined extracranial arteries (ie, carotid intima-media thickening, 50%–100% carotid stenosis, an ankle-brachial index of ≤0.9, and renal dysfunction), leading the authors to conclude that contrary to popular belief, intracranial and extracranial atherosclerosis were more similar than different in atherogenic mechanisms and etiology. Literature on the relationship between systemic and intracranial atherosclerotic disease is scant and wanting. A recent French study of 403 patients with stroke by Hoshino et al12 found significant ($50%) intracranial atherosclerotic stenosis in only a 36.2% minority by lumenographic imaging, with concomitant aortic arch and coronary artery atherosclerosis more often coexisting. While the male-dominant cohort studied by Zwartbol et al11 is small in epidemiologic terms, it is valuable and useful as one of the largest studied with 7T vessel wall MR imaging to date.7,9 The analysis of extracranial atherosclerosis was comprehensive, and the team should be commended for their clear and succinct charting of the markers of extracranial atherosclerosis and assessment of vascular risk factors. The authors are well-established and competent in vessel wall imaging assessment.13 Improved accuracy with ultra-high-field in vivo vessel wall MR imaging14 and a detailed description of vessel wall lesion rating criteria lend credibility to their findings of high intracranial plaque burden, which were consistent with postmortem reporting of plaque frequency and distribution.15 We eagerly await validation of these findings in larger prospective population studies incorporating intracranial vessel wall MR imaging with systemic atherosclerosis assessment, and especially in vulnerable cohorts such as Asians and Africans.1,3 Future evaluation of luminal stenosis and vessel wall MR imaging in tandem, in addition to brain ischemic events, would allow even more comprehensive appraisal and characterization of intracranial atherosclerotic burden with respect to severity, vascular remodeling, and hemodynamic impact. Technologic and protocol refinements further reducing scan time, while maintaining spatial and contrast resolution,13 could also make vessel wall MR imaging more clinically accessible to the patient in this age of precision medicine and could deepen our insights into stroke pathophysiology. ## References 1. 1.Qureshi AI, Caplan LR. Intracranial atherosclerosis. Lancet 2014;383:984–98 doi:10.1016/S0140-6736(13)61088-0 pmid:24007975 [CrossRef](http://www.ajnr.org/lookup/external-ref?access_num=10.1016/S0140-6736(13)61088-0&link_type=DOI) [PubMed](http://www.ajnr.org/lookup/external-ref?access_num=24007975&link_type=MED&atom=%2Fajnr%2F40%2F12%2F2023.atom) 2. 2.Hopkins PN. Molecular biology of atherosclerosis. Physiol Rev 2013;93:1317–542 doi:10.1152/physrev.00004.2012 pmid:23899566 [CrossRef](http://www.ajnr.org/lookup/external-ref?access_num=10.1152/physrev.00004.2012&link_type=DOI) [PubMed](http://www.ajnr.org/lookup/external-ref?access_num=23899566&link_type=MED&atom=%2Fajnr%2F40%2F12%2F2023.atom) 3. 3.Bravata DM, Wells CK, Gulanski B, et al. Racial disparities in stroke risk factors: the impact of socioeconomic status. Stroke 2005;36:1507–11 doi:10.1161/01.STR.0000170991.63594.b6 pmid:15961710 [Abstract/FREE Full Text](http://www.ajnr.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6OToic3Ryb2tlYWhhIjtzOjU6InJlc2lkIjtzOjk6IjM2LzcvMTUwNyI7czo0OiJhdG9tIjtzOjIxOiIvYWpuci80MC8xMi8yMDIzLmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==) 4. 4.Kiechl S, Willeit J. Group for the BS. The natural course of atherosclerosis, Part I: incidence and progression. Arter Thromb Vasc Biol 1999;19:1484–90 doi:10.1161/01.atv.19.6.1484 pmid:10364079 [Abstract/FREE Full Text](http://www.ajnr.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NzoiYXR2YmFoYSI7czo1OiJyZXNpZCI7czo5OiIxOS82LzE0ODQiO3M6NDoiYXRvbSI7czoyMToiL2FqbnIvNDAvMTIvMjAyMy5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=) 5. 5.Ritz K, Denswil NP, Stam O, et al. Cause and mechanisms of intracranial atherosclerosis. Circulation 2014;130:1407–14 doi:10.1161/CIRCULATIONAHA.114.011147 pmid:25311618 [FREE Full Text](http://www.ajnr.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiRlVMTCI7czoxMToiam91cm5hbENvZGUiO3M6MTQ6ImNpcmN1bGF0aW9uYWhhIjtzOjU6InJlc2lkIjtzOjExOiIxMzAvMTYvMTQwNyI7czo0OiJhdG9tIjtzOjIxOiIvYWpuci80MC8xMi8yMDIzLmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==) 6. 6.Holmstedt CA, Turan TN, Chimowitz MI. Atherosclerotic intracranial arterial stenosis: risk factors, diagnosis, and treatment. Lancet Neurol 2013;12:1106–14 doi:10.1016/S1474-4422(13)70195-9 pmid:24135208 [CrossRef](http://www.ajnr.org/lookup/external-ref?access_num=10.1016/S1474-4422(13)70195-9&link_type=DOI) [PubMed](http://www.ajnr.org/lookup/external-ref?access_num=24135208&link_type=MED&atom=%2Fajnr%2F40%2F12%2F2023.atom) 7. 7.Qiao Y, Suri FK, Zhang Y, et al. Racial differences in prevalence and risk for intracranial atherosclerosis in a US community-based population. JAMA Cardiol 2017;2:1341–48 doi:10.1001/jamacardio.2017.4041 pmid:29094154 [CrossRef](http://www.ajnr.org/lookup/external-ref?access_num=10.1001/jamacardio.2017.4041&link_type=DOI) [PubMed](http://www.ajnr.org/lookup/external-ref?access_num=29094154&link_type=MED&atom=%2Fajnr%2F40%2F12%2F2023.atom) 8. 8.López-Cancio E, Galán A, Dorado L, et al. Biological signatures of asymptomatic extra- and intracranial atherosclerosis: the Barcelona-AsIA (Asymptomatic Intracranial Atherosclerosis) study. Stroke 2012;43:2712–19 doi:10.1161/STROKEAHA.112.661702 pmid:22798326 [Abstract/FREE Full Text](http://www.ajnr.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6OToic3Ryb2tlYWhhIjtzOjU6InJlc2lkIjtzOjEwOiI0My8xMC8yNzEyIjtzOjQ6ImF0b20iO3M6MjE6Ii9ham5yLzQwLzEyLzIwMjMuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9) 9. 9.Qiao Y, Guallar E, Suri FK, et al. MR imaging measures of intracranial atherosclerosis in a population-based study. Radiology 2016;280:860–68 doi:10.1148/radiol.2016151124 pmid:27022858 [CrossRef](http://www.ajnr.org/lookup/external-ref?access_num=10.1148/radiol.2016151124&link_type=DOI) [PubMed](http://www.ajnr.org/lookup/external-ref?access_num=27022858&link_type=MED&atom=%2Fajnr%2F40%2F12%2F2023.atom) 10. 10.Qiao Y, Anwar Z, Intrapiromkul J, et al. Patterns and implications of intracranial arterial remodeling in stroke patients. Stroke 2016;47:434–40 doi:10.1161/STROKEAHA.115.009955 pmid:26742795 [Abstract/FREE Full Text](http://www.ajnr.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6OToic3Ryb2tlYWhhIjtzOjU6InJlc2lkIjtzOjg6IjQ3LzIvNDM0IjtzOjQ6ImF0b20iO3M6MjE6Ii9ham5yLzQwLzEyLzIwMjMuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9) 11. 11.Zwartbol MH, Geerlings MI, Ghaznawi R, et al. Intracranial atherosclerotic burden on 7T MRI is associated with markers of extracranial atherosclerosis: the SMART-MR study. AJNR Am J Neuroradiol 2019:40 12. 12.Hoshino T, Sissani L, Labreuche J, et al; AMISTAD Investigators. Prevalence of systemic atherosclerosis burdens and overlapping stroke etiologies and their associations with long-term vascular prognosis in stroke with intracranial atherosclerotic disease. JAMA Neurol 2018;75:203–11 doi:10.1001/jamaneurol.2017.3960 pmid:29279888 [CrossRef](http://www.ajnr.org/lookup/external-ref?access_num=10.1001/jamaneurol.2017.3960&link_type=DOI) [PubMed](http://www.ajnr.org/lookup/external-ref?access_num=29279888&link_type=MED&atom=%2Fajnr%2F40%2F12%2F2023.atom) 13. 13.Lindenholz A, van der Kolk AG, Zwanenburg JJM, et al. The use and pitfalls of intracranial vessel wall imaging: how we do it. Radiology 2018;286:12–28 doi:10.1148/radiol.2017162096 pmid:29261469 [CrossRef](http://www.ajnr.org/lookup/external-ref?access_num=10.1148/radiol.2017162096&link_type=DOI) [PubMed](http://www.ajnr.org/lookup/external-ref?access_num=29261469&link_type=MED&atom=%2Fajnr%2F40%2F12%2F2023.atom) 14. 14.Harteveld AA, van der Kolk AG, van der Worp HB, et al. High-resolution intracranial vessel wall MRI in an elderly asymptomatic population: comparison of 3T and 7T. Eur Radiol 2017;27:1585–95 doi:10.1007/s00330-016-4483-3 pmid:27387876 [CrossRef](http://www.ajnr.org/lookup/external-ref?access_num=10.1007/s00330-016-4483-3&link_type=DOI) [PubMed](http://www.ajnr.org/lookup/external-ref?access_num=27387876&link_type=MED&atom=%2Fajnr%2F40%2F12%2F2023.atom) 15. 15.Resch JA, Baker AB. Etiologic mechanisms in cerebral atherosclerosis: preliminary study of 3,839 cases. Arch Neurol 1964;10:617–28 doi:10.1001/archneur.1964.00460180083008 pmid:14130420 [CrossRef](http://www.ajnr.org/lookup/external-ref?access_num=10.1001/archneur.1964.00460180083008&link_type=DOI) [PubMed](http://www.ajnr.org/lookup/external-ref?access_num=14130420&link_type=MED&atom=%2Fajnr%2F40%2F12%2F2023.atom) [Web of Science](http://www.ajnr.org/lookup/external-ref?access_num=A19645712A00004&link_type=ISI) * © 2019 by American Journal of Neuroradiology